Ganciclovir pharmacokinetics during renal impairment.

Limited information is available concerning the use of ganciclovir (GCV) in patients with severe renal impairment. The pharmacokinetics of GCV were studied in a heart transplant recipient requiring hemodialysis. The total body clearance was calculated to be approximately 5% of that previously report...

Cijeli opis

Bibliografski detalji

Izdano u:	Antimicrob Agents Chemother
Glavni autori:	Lake, K D, Fletcher, C V, Love, K R, Brown, D C, Joyce, L D, Pritzker, M R
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Microbiology (ASM) 1988
Teme:	Research Article
Online pristup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC176042/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2854457/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.32.12.1899
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!